Want to see AMGN full AI Analyst Report?
Amgen (AMGN) Stock Forecast & Price Target
7,031 Followers
AMGN Analyst Ratings
Moderate Buy
9Buy17Hold1Sell
Based on 27 analysts giving stock ratings to Amgen in the past 3 months
AMGN Stock 12 Month Forecast
Average Price Target
$449.68▼(-2.30% Downside)Based on 27 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $449.68 with a high forecast of $536.00 and a low forecast of $347.00. The average price target represents a -2.30% change from the last price of $460.28.
Past 12 Months12 Month ForecastJan2026Oct2026
High$536.00
Average$449.68
Low$347.00
Highest Price TargetHighest$536.00Average Price Target$449.68Lowest Price TargetLowest$347.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Ilya Zubkov | Freedom Capital Markets | $450→$470 | hold | 2.11%Upside | Downgraded | 11/06/26 | ||
| Geoff Meacham | Citi | $405→$465 | hold | 1.03%Upside | Reiterated | 11/05/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | $395→$464 | hold | 0.81%Upside | Reiterated | 11/05/26 | ||
| Mohit Bansal | Wells Fargo | $430→$460 | hold | -0.06%Downside | Assigned | 11/04/26 | ||
| Salveen Richter | Goldman Sachs | $481→$536 | buy | 16.45%Upside | Reiterated | 11/04/26 | ||
| Tazeen Ahmad | Bank of America Securities | $328→$347 | sell | -24.61%Downside | Reiterated | 11/04/26 | ||
| Gary Nachman | Canaccord Genuity | $384→$440 | hold | -4.41%Downside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | $430→$470 | buy | 2.11%Upside | Assigned | 11/04/26 | ||
| Chris Schott | J.P. Morgan | $350→$425 | hold | -7.66%Downside | Reiterated | 11/04/26 | ||
| Courtney Breen | Bernstein | $345→$400 | hold | -13.10%Downside | Assigned | 11/04/26 | ||
| Evan Seigerman | BMO Capital | $415→$442 | hold | -3.97%Downside | Reiterated | 11/04/26 | ||
| Louise Chen | Scotiabank | $500→$530 | buy | 15.15%Upside | Reiterated | 11/04/26 | ||
| Michael Yee | UBS | $470→$530 | buy | 15.15%Upside | Reiterated | 11/04/26 | ||
| David Amsellem | Piper Sandler | $457 | buy | -0.71%Downside | Reiterated | 11/04/26 | ||
| Yaron Werber | TD Cowen | $452→$531 | buy | 15.36%Upside | Reiterated | 11/04/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Ilya ZubkovFreedom Capital Markets | HoldDowngraded$450→$470 | 11/06/26 | 2.11%Upside | ||
| Geoff MeachamCiti | HoldReiterated$405→$465 | 11/05/26 | 1.03%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | HoldReiterated$395→$464 | 11/05/26 | 0.81%Upside | ||
| Mohit BansalWells Fargo | HoldAssigned$430→$460 | 11/04/26 | -0.06%Downside | ||
| Salveen RichterGoldman Sachs | BuyReiterated$481→$536 | 11/04/26 | 16.45%Upside | ||
| Tazeen AhmadBank of America Securities | SellReiterated$328→$347 | 11/04/26 | -24.61%Downside | ||
| Gary NachmanCanaccord Genuity | HoldReiterated$384→$440 | 11/04/26 | -4.41%Downside | ||
| Luca IssiRBC Capital | BuyAssigned$430→$470 | 11/04/26 | 2.11%Upside | ||
| Chris SchottJ.P. Morgan | HoldReiterated$350→$425 | 11/04/26 | -7.66%Downside | ||
| Courtney BreenBernstein | HoldAssigned$345→$400 | 11/04/26 | -13.10%Downside | ||
| Evan SeigermanBMO Capital | HoldReiterated$415→$442 | 11/04/26 | -3.97%Downside | ||
| Louise ChenScotiabank | BuyReiterated$500→$530 | 11/04/26 | 15.15%Upside | ||
| Michael YeeUBS | BuyReiterated$470→$530 | 11/04/26 | 15.15%Upside | ||
| David AmsellemPiper Sandler | BuyReiterated$457 | 11/04/26 | -0.71%Downside | ||
| Yaron WerberTD Cowen | BuyReiterated$452→$531 | 11/04/26 | 15.36%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Amgen
3 Months
Success Rate16/22 ratings generated profit
73%
Average Return
+6.72%
Copying David Amsellem's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +6.72% per trade.
1 Year
Success Rate21/22 ratings generated profit
95%
Average Return
+28.59%
Copying David Amsellem's trades and holding each position for 1 Year would result in 95.45% of your transactions generating a profit, with an average return of +28.59% per trade.
2 Years
Success Rate29/30 ratings generated profit
97%
Average Return
+29.91%
Copying Jay Olson's trades and holding each position for 2 Years would result in 96.67% of your transactions generating a profit, with an average return of +29.91% per trade.
AMGN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 19 | 24 | 34 | 41 | 33 |
| Hold | 22 | 26 | 39 | 47 | 45 |
| Sell | 2 | 3 | 5 | 6 | 5 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 43 | 53 | 78 | 94 | 83 |
In the current month, AMGN has received 33 Buy Ratings, 45 Hold Ratings, and 5 Sell Ratings. AMGN average Analyst price target in the past 3 months is 449.68.
AMGN Financial Forecast
High$6.08
Consensus$5.65
Low$5.13
AMGN Earnings Forecast
Next quarter’s earnings estimate for AMGN is $5.65 with a range of $5.13 to $6.08. The previous quarter’s EPS was $6.45. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$10.8B
Consensus$10.4B
Low$10.2B
AMGN Sales Forecast
Next quarter’s sales forecast for AMGN is $10.45B with a range of $10.21B to $10.77B. The previous quarter’s sales results were $10.36B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
AMGN Stock Forecast FAQ
What is AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is $449.68.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AMGN a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy which is based on 9 buy ratings, 17 hold ratings and 1 sell ratings.
What is Amgen’s price target?
The average price target for Amgen is $449.68. This is based on 27 12-month price targets, issued in the past 3 months. The highest analyst price target is $536.00, the lowest forecast is $347.00. The average price target represents a 2.30% decrease from the current price of $460.28.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Street analysts.
How can I buy shares of AMGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
